Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wielinga

Showing results (41-50 of 98) with videos related to

Pageof 10
Sort By:
Plos One|September 10, 2008
Vaccination against GIP for the treatment of obesityAlma Fulurija, Thomas A Lutz, Katja Sladko, et al.
The Biochemical Journal|January 14, 2003
Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4)Noam Zelcer, Glen Reid, Peter Wielinga, et al.
Atherosclerosis|May 24, 2011
Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo modelsRobert Kleemann, Lars Verschuren, Martine Morrison, et al.
Antiviral Research|March 18, 2004
The potential impact of drug transporters on nucleoside-analog-based antiviral chemotherapyP Borst, J Balzarini, N Ono, et al.
Neuroreport|December 20, 2007
In-vitro and in-vivo antagonistic action of an anti-amylin SpiegelmerKerstin U Bilik, Elif Ergüven, Sven Klussmann, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|September 2, 2008
Persistent detection of Babesia EU1 and Babesia microti in Ixodes ricinus in the Netherlands during a 5-year surveillance: 2003-2007Peter R Wielinga, Manoj Fonville, Hein Sprong, et al.
Molecular Pharmacology|April 16, 2003
Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5Glen Reid, Peter Wielinga, Noam Zelcer, et al.
Parasites & Vectors|September 24, 2008
Giardia assemblage A: human genotype in muskoxen in the Canadian ArcticSusan J Kutz, Rc Andrew Thompson, Lydden Polley, et al.
BMC Medical Genomics|June 19, 2014
A systems biology approach to understand the pathophysiological mechanisms of cardiac pathological hypertrophy associated with rosiglitazoneLars Verschuren, Peter Y Wielinga, Thomas Kelder, et al.
Atherosclerosis|May 30, 2016
Resolvin E1 attenuates atherosclerosis in absence of cholesterol-lowering effects and on top of atorvastatinKanita Salic, Martine C Morrison, Lars Verschuren, et al.
Pageof 10

Showing results (41-50 of 98) with videos related to

Sort By:
Pageof 10
Plos One|September 10, 2008
Vaccination against GIP for the treatment of obesityAlma Fulurija, Thomas A Lutz, Katja Sladko, et al.
The Biochemical Journal|January 14, 2003
Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4)Noam Zelcer, Glen Reid, Peter Wielinga, et al.
Atherosclerosis|May 24, 2011
Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo modelsRobert Kleemann, Lars Verschuren, Martine Morrison, et al.
Antiviral Research|March 18, 2004
The potential impact of drug transporters on nucleoside-analog-based antiviral chemotherapyP Borst, J Balzarini, N Ono, et al.
Neuroreport|December 20, 2007
In-vitro and in-vivo antagonistic action of an anti-amylin SpiegelmerKerstin U Bilik, Elif Ergüven, Sven Klussmann, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|September 2, 2008
Persistent detection of Babesia EU1 and Babesia microti in Ixodes ricinus in the Netherlands during a 5-year surveillance: 2003-2007Peter R Wielinga, Manoj Fonville, Hein Sprong, et al.
Molecular Pharmacology|April 16, 2003
Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5Glen Reid, Peter Wielinga, Noam Zelcer, et al.
Parasites & Vectors|September 24, 2008
Giardia assemblage A: human genotype in muskoxen in the Canadian ArcticSusan J Kutz, Rc Andrew Thompson, Lydden Polley, et al.
BMC Medical Genomics|June 19, 2014
A systems biology approach to understand the pathophysiological mechanisms of cardiac pathological hypertrophy associated with rosiglitazoneLars Verschuren, Peter Y Wielinga, Thomas Kelder, et al.
Atherosclerosis|May 30, 2016
Resolvin E1 attenuates atherosclerosis in absence of cholesterol-lowering effects and on top of atorvastatinKanita Salic, Martine C Morrison, Lars Verschuren, et al.
Pageof 10